177 related articles for article (PubMed ID: 36471191)
1. Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child-Pugh Class B: a Retrospective Multicenter Study.
Tanaka S; Noda T; Komeda K; Kosaka H; Iida H; Ueno M; Hokuto D; Ikoma H; Nakai T; Kabata D; Shinkawa H; Kobayashi S; Hirokawa F; Mori H; Hayami S; Morimura R; Matsumoto M; Ishizawa T; Kubo S; Kaibori M
J Gastrointest Surg; 2023 Feb; 27(2):283-295. PubMed ID: 36471191
[TBL] [Abstract][Full Text] [Related]
2. Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection.
Tsai YC; Sou FM; Liu YW; Wu YJ; Yong CC; Chen DW; Huang PY; Cho WR; Chuang CH; Hsiao CC; Hu TH; Tsai MC
BMC Gastroenterol; 2021 Oct; 21(1):386. PubMed ID: 34666694
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract][Full Text] [Related]
4. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
5. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
6. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
[TBL] [Abstract][Full Text] [Related]
7. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
[TBL] [Abstract][Full Text] [Related]
8. ASARA, a prediction model based on Child-Pugh class in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Jia KF; Wang H; Yu CL; Yin WL; Zhang XD; Wang F; Sun C; Shen W
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):490-497. PubMed ID: 35260337
[TBL] [Abstract][Full Text] [Related]
9. Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
Hsieh CB; Chen TW; Chu CM; Chu HC; Yu CP; Chung KP
World J Gastroenterol; 2010 Jun; 16(24):3049-55. PubMed ID: 20572309
[TBL] [Abstract][Full Text] [Related]
10. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
Liang X; Liangliang X; Peng W; Tao Y; Jinfu Z; Ming Z; Mingqing X
Sci Rep; 2021 Jul; 11(1):14624. PubMed ID: 34272447
[TBL] [Abstract][Full Text] [Related]
11. Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma.
Tan XP; Zhou K; Zeng QL; Yuan YF; Chen W
Clin Exp Med; 2023 Feb; 23(1):107-115. PubMed ID: 35293607
[TBL] [Abstract][Full Text] [Related]
12. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
13. Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence?
Yu MC; Chan KM; Lee CF; Lee YS; Eldeen FZ; Chou HS; Lee WC; Chen MF
J Gastrointest Surg; 2011 Aug; 15(8):1440-9. PubMed ID: 21541770
[TBL] [Abstract][Full Text] [Related]
14. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of alpha fetoprotein with the prognosis of hepatocellular carcinoma after hepatectomy in an ethnic Chinese population].
Bi X; Yan T; Zhao H; Zhao J; Li Z; Huang Z; Zhou J; Cai J
Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(34):2645-9. PubMed ID: 25511589
[TBL] [Abstract][Full Text] [Related]
17. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
[TBL] [Abstract][Full Text] [Related]
18. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
19. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis.
Risaliti M; Bartolini I; Campani C; Arena U; Xodo C; Adotti V; Rosi M; Taddei A; Muiesan P; Amedei A; Batignani G; Marra F
World J Gastroenterol; 2022 Aug; 28(29):3981-3993. PubMed ID: 36157535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
